HPV Vaccine Cuts Cervical Cancer Cases by Almost 90%–But in Ten Girls Still Haven’t Been Vaccinated

November 5, 2021

(The Conversation) – A vaccine to protect against human papillomavirus (HPV) has been found to cut cases of cervical cancer by nearly 90%, according to a recent study published in The Lancet. Cervical cancer, which can be caused by HPV, is one of the few cancers that can be prevented by a vaccine. This is why the HPV vaccination programme was introduced in UK schools in 2008, offered to girls aged 12-13. The programme has been extremely successful in the UK, with over 80% of eligible girls having received it to date. But our research has shown that there are still gaps in the vaccination programme.  (Read Full Article)